Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: NIH s Mammalian Gene Project to Use Agencourt s cDNA Technology

NEW YORK, Jan. 21 - Agencourt Bioscience is set to announce on Tuesday that it will provide genomic services to the Mammalian Gene Collection project of the National Institutes of Health.

Terms of the agreement, funded through a federal contract, call for Agencourt to use its Solid Phase Reversible Immobilization technology to sequence tag mammalian cDNAs and help MGC identify and sequence full-length cDNAs, according to Agencourt.

The project's goal is to identify and sequence a representative full open reading frame clone for each human and mouse gene to be used as a reference for genotyping and haplotyping. It is being carried out by a range of partners, including Clontech and Agencourt.

Although financial details of the deal are not known at this time, Agencourt said that all resources generated by the MGC project will be publicly accessible.

Agencourt, based in Beverly, Mass., provides DNA sequencing, DNA purification, and SNP genotyping services and products to companies in genomics research.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.